Sang-Jae Kim

Sang-Jae Kim

Chief Executive Officer at SAMSUNG PHARM. CO., LTD.

Net worth: 72 M $ as of 30/04/2024

57 year
Health Technology
Electronic Technology
Retail Trade

Sang-Jae Kim active positions

CompaniesPositionStartEnd
SAMSUNG PHARM. CO., LTD. Director/Board Member - -
Chief Executive Officer 26/06/2015 -
Corporate Officer/Principal 31/12/2014 -
GEMVAXLINK CO., LTD. Director/Board Member 14/03/2017 -
Chief Executive Officer 14/03/2017 -
FLASK CO., LTD. Director/Board Member - -
Chief Executive Officer - -
Chief Executive Officer 06/09/2011 -
Chief Executive Officer - -
Director/Board Member - -
Gemvax USA, Inc. Chief Executive Officer - -
Teloid, Inc. Chief Executive Officer - -

Career history of Sang-Jae Kim

Former positions of Sang-Jae Kim

CompaniesPositionStartEnd
GEMVAX&KAEL CO.,LTD. Director/Board Member 30/05/2008 01/01/2024
Chief Executive Officer 30/05/2008 01/01/2024
░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ - -
░░░░░ ░░░░ ░░░░ ░░░░ ░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ -
░░░░░░ ░░░░ ░░░░ ░░░░░░░░░ - -

Training of Sang-Jae Kim

Hanyang University Doctorate Degree

Statistics

International

South Korea 11
United States 3
Norway 2

Operational

Chief Executive Officer 10
Director/Board Member 8
President 1

Sectoral

Health Technology 5
Electronic Technology 3
Retail Trade 2

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Listed companies4
SAMSUNG PHARM. CO., LTD.

Health Technology

GEMVAXLINK CO., LTD.

Retail Trade

FLASK CO., LTD.

Electronic Technology

GEMVAX&KAEL CO.,LTD.

Producer Manufacturing

Private companies9

Health Technology

Process Industries

Electronic Technology

Commercial Services

Finance

Health Technology

Health Technology

Gemvax USA, Inc.

Teloid, Inc.

See company connections
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW